يعرض 1 - 10 نتائج من 13 نتيجة بحث عن '"human epidermal growth factor receptor 2"', وقت الاستعلام: 0.88s تنقيح النتائج
  1. 1

    المصدر: Saudi Journal of Biological Sciences
    Saudi Journal of Biological Sciences, Vol 28, Iss 11, Pp 6289-6296 (2021)

  2. 2

    المصدر: Neoplasia: An International Journal for Oncology Research, Vol 21, Iss 10, Pp 1015-1035 (2019)
    Neoplasia (New York, N.Y.)

  3. 3

    المصدر: Translational Oncology, Vol 14, Iss 1, Pp 100946-(2021)
    Translational Oncology

  4. 4
  5. 5

    المصدر: Journal of Bone Oncology, Vol 24, Iss, Pp 100304-(2020)
    Journal of Bone Oncology

  6. 6

    المصدر: EBioMedicine
    EBioMedicine, Vol 32, Iss, Pp 111-118 (2018)

    مصطلحات موضوعية: 0301 basic medicine, Oncology, MBC, metastatic breast cancer, ER, estrogen receptor, Receptor, ErbB-2, Gene mutation pattern, Estrogen receptor, lcsh:Medicine, Drug resistance, SNV, Single nucleotide variants, Gene mutation, medicine.disease_cause, Circulating Tumor DNA, SEER, Surveillance Epidemiology and End Results, AUC, area under the curve, Phosphatidylinositol 3-Kinases, 0302 clinical medicine, HER2, human epidermal growth factor receptor 2, ctDNA, circulating tumor DNA, Indels, insertions and deletions, Neoplasm Metastasis, skin and connective tissue diseases, Triple-negative breast cancer, TNBC, triple negative breast cancer, Mutation, lcsh:R5-920, Mediator Complex, BRCA1 Protein, Progression-free survival, General Medicine, Middle Aged, Metastatic breast cancer, PFS, progression-free survival, Drug Resistance, Multiple, Gene Expression Regulation, Neoplastic, GX, gemcitabine+capecitabine, 030220 oncology & carcinogenesis, Disease Progression, Female, lcsh:Medicine (General), Circulating tumor DNA (ctDNA), WES, whole exome sequencing, IHC, immunohistochemistry, Research Paper, Adult, medicine.medical_specialty, Class I Phosphatidylinositol 3-Kinases, Breast Neoplasms, General Biochemistry, Genetics and Molecular Biology, Disease-Free Survival, 03 medical and health sciences, Internal medicine, medicine, Biomarkers, Tumor, Humans, neoplasms, AI, aromatase inhibitor, Aged, HR/HER2 subtype, TMB, Tumor mutation burden, business.industry, lcsh:R, Cancer, HR, hormone receptor, PR, progesterone receptor, cfDNA, cell-free DNA, medicine.disease, HR, hazard ratio, ROC, receiver operating characteristic, CI, confidence interval, 030104 developmental biology, Drug Resistance, Neoplasm, gDNA, genomic DNA, Tumor Suppressor Protein p53, business

  7. 7

    المصدر: Journal of Bone Oncology, Vol 8, Iss C, Pp 18-22 (2017)
    Journal of Bone Oncology

  8. 8

    المصدر: Journal of Bone Oncology, Vol 16, Iss, Pp-(2019)
    Journal of Bone Oncology

    مصطلحات موضوعية: lcsh:Diseases of the musculoskeletal system, MMP2/9, matrix metalloproteinase-2/9, SCF, stem cells factor, medicine.medical_treatment, Review Article, CCL5, chemokine ligand 5, TNF, tumour necrosis factor, Regenerative medicine, APCs, antigen presenting cells, 0302 clinical medicine, Stromal, Medicine, HER2, human epidermal growth factor receptor 2, TNF-a, tumour necrosis factor alpha, IL-6, interleukin-6, Sarcoma, MCP-1, monocyte chemoattractant protein-1, TGF-b1, transforming growth factor beta 1, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, ECM, extracellular matrix, hMSCs, human mesenchymal stromal cells, IFN-β, interferon beta, VEGFR, vascular endothelial growth factor receptor, Oncology, 030220 oncology & carcinogenesis, MMP-2, matrix metalloproteinase-2, CXCL12/CXCR7, C-X-C chemokine ligand 12/ C-X-C chemokine receptor 7, GD2, disialoganglioside 2, IL11RA, Interleukin 11 Receptor Subunit Alpha, CXCR4, chemokine receptor type 4, lcsh:RC254-282, CCR2, chemokine receptor 2, 03 medical and health sciences, IL-1b, interleukin-1b, PGE2, prostaglandin E2, TAAs, tumour-associated antigens, Regeneration, ASC, adipose-derived stromal/stem cells, Bone regeneration, Biology, Tissue, CD, classification determinants, IFN-γ, interferon gamma, DKK1, dickkopf-related protein 1, Mesenchymal stem cell, Orthopaedic, medicine.disease, Radiation therapy, 030104 developmental biology, IGF-1R, insulin-like growth factor 1 receptor, OPG, osteoprotegerin, Cancer cell, FGF-2, fibroblast growth factors-2, Cell, CLUAP1, clusterin associated protein 1, RES, reticuloendothelial system, CAM, cell adhesion molecules, CSPG4, Chondroitin sulfate proteoglycan 4, IL-2a, interleukin-2a, 0301 basic medicine, MAGE, melanoma antigen gene, PDGF, platelet-derived growth factor, HMGB1/RACE, high mobility group box-1 protein/ receptor for advanced glycation end-products, PI3K/Akt, phosphoinositide 3-kinase/protein kinase B, BD, bone defect, TRAIL, tumour necrosis factor related apoptosis-inducing ligand, BMMSCs, bone marrow-derived mesenchymal stromal cells, IL-8, interleukin-8, PEDF, pigment epithelium-derived factor, TCR, T cell receptor, IL-21, interleukin-21, NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells, IL-18, interleukin-18, IL-10, interleukin-10, VEGF, vascular endothelial growth factor, IDO, indoleamine 2,3-dioxygenase, EMT, epithelial-mesenchymal transition, CX3CL1, chemokine (C-X3-C motif) ligand 1, MRP, multidrug resistance protein, TGF-b, transforming growth factor beta, Mesenchymal, Stromal cell, CXCL12/CXCR4, C-X-C chemokine ligand 12/ C-X-C chemokine receptor 4, PBS, phosphate-buffered saline, RANK, receptor activator of nuclear factor kappa-B, Bone Sarcoma, IFN-α, interferon alpha, STAT-3, signal transducer and activator of transcription 3, PDX, patient derived xenograft, RANKL, receptor activator of nuclear factor kappa-B ligand, SDF-1, stromal cell-derived factor 1, IL-12, interleukin-12, MSCs, mesenchymal stem/stromal cells, 5-FC, 5-fluorocytosine, Bone, WBCs, white blood cell, business.industry, AAT, a1-antitrypsin, PTX, paclitaxel, Ang1, angiopoietin-1, rh-TRAIL, recombinant human tumour necrosis factor related apoptosis-inducing ligand, CD, cytosine deaminase, RBCs, red blood cells, RNA, ribonucleic acid, Cancer research, FGF-7, fibroblast growth factors-7, SC, stem cells, HGF, hepatocyte growth factor, DBM, Demineralized Bone Marrow, lcsh:RC925-935, business, Abs, antibodies

  9. 9

    المصدر: Journal of Bone Oncology, Vol 15, Iss, Pp-(2019)
    Journal of Bone Oncology

    مصطلحات موضوعية: TKIs, TK inhibitors, 0301 basic medicine, Oncology, lcsh:Diseases of the musculoskeletal system, DFS, disease-free survival, Bone disease, medicine.medical_treatment, Bone targeting agents, BTA, bone targeting agents, GFs, growth factors, Review Article, Skeletal related events, CRPC, castration-resistant PC, PDGF, platelet-derived growth factor, Prostate cancer, PIs, proteasome inhibitors, SREs, skeletal-related events, 0302 clinical medicine, BTM, bone turnover markers, HER-2, human epidermal growth factor receptor 2, PTH, parathyroid hormone, CXCL-12, C–X–C motif chemokine-ligand-12, MPC, malignant plasma cells, SSEs, symptomatic skeletal events, TGF-β, transforming growth factor β, DKK1, dickkopf1, RANK-L, receptor activator of NF-κB ligand, MM, multiple myeloma, N-BPs, nitrogen-containing BPs, Bone metastasis, RT, radiation therapy, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, VEGF, vascular endothelial growth factor, humanities, CCR, chemokine-receptor, PFS, progression-free survival, ECM, extracellular matrix, PTH-rP, PTH related protein, Osteotropic tumors, Denosumab, BPs, bisphosphonates, 030220 oncology & carcinogenesis, GAS6, growth-arrest specific-6, MIP-1α, macrophage inflammatory protein-1 alpha, Adjuvant, medicine.drug, medicine.medical_specialty, BC, breast cancer, PC, prostate cancer, BMD, bone mineral density, EBC, early BC, NF-κB, nuclear factor-κB, mTOR, mammalian target of rapamycin, LC, lung cancer, lcsh:RC254-282, BM, bone metastases, OS, overall survival, 03 medical and health sciences, Breast cancer, MCSF, macrophage colony-stimulating factor, Internal medicine, BMSC, bone marrow stromal cells, medicine, ET-1, endothelin-1, GnRH, gonadotropin-releasing hormone, v-ATPase, vacuolar-type H+ ATPase, VEGFR, VEGF receptor, business.industry, Bone metastases, TK, tyrosine kinase, HR, hormone receptor, Cancer, ONJ, osteonecrosis of the jaw, medicine.disease, QoL, quality of life, FGF, fibroblast growth factor, IL, interleukin, BMPs, bone morphogenetic proteins, Clinical trial, non-N-BPs, non-nitrogen containing BPs, PSA, prostate specific antigen, 030104 developmental biology, FDA, food and drug administration, TNF, tumornecrosis factor, CXCR-4, chemokine-receptor-4, MCSFR, MCSF receptor, ActRIIA, activin-A type IIA receptor, lcsh:RC925-935, business, MAPK, mitogen-activated protein kinase

  10. 10

    المصدر: Biochemistry and Biophysics Reports
    Biochemistry and Biophysics Reports, Vol 18, Iss, Pp-(2019)